Nasdaq:US$ () | HKEX:HK$ () | AIM:£1.58 (+0.06)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713